Vimarsana
Biggest News Aggregation in the World

Page 17 - Trials Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trials Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trials Unit Today - Breaking & Trending Today

Novavax Covid-19 vaccine: Western Trust team join volunteers - Vimarsana News

Novavax Covid-19 vaccine: Western Trust team join volunteers

STAFF from the Western Health and Social Trust (Western Trust) joined volunteers from across Northern Ireland (NI) to take part in a milestone study into the new Novavax Covid-19 vaccine. Three members of the Western Trust Research Team – research nurses Dawn Small, Caitriona Lavery and Donal Concannon – all played an important role within the project. The study was a large UK-wide research initiative which aimed to assess the effectiveness of the Novavax vaccine against Covid-19, involving more than 15,000 participants. After successful trials, the interim study results reported ...

Coronavirus: Glasgow researchers to test whether flu pill can stop Covid - Vimarsana News

Coronavirus: Glasgow researchers to test whether flu pill can stop Covid

Antiviral tablet Favipiravir is already used in Japan for flu, and is made by Fujifilm Toyama Chemicals. It is now being trialled for use in Covid patients with milder symptoms by scientists in Glasgow who hope it could stop them developing serious ones. It has to be taken within four days of a positive test and NHS Greater Glasgow and Clyde and the University of Glasgow are urging people who have been diagnosed with the infection to take part in a new study. The tablet can be taken at home, twice a day, and is intended for people with milder symptoms than those requiring hospital adm...

Covid Scotland: NHS Greater Glasgow and Clyde call on public to help trial new treatment - Vimarsana News

Covid Scotland: NHS Greater Glasgow and Clyde call on public to help trial new treatment

Researchers and clinicians are recruiting members of the public to help test new Covid-19 treatment

Funding for COVID-19 overshadows HIV/TB research expense - Vimarsana News

Funding for COVID-19 overshadows HIV/TB research expense

National February 6, 2021 LAHORE: Global funding for COVID-19 vaccine development has exceeded 10 times in less than a year the amount allocated for HIV and TB research and development in 11 years. “A staggering amount of $103.8 billion has been thrust into COVID-19 vaccine development within a period of just 11 months of 2020 as compared to a paltry $9.5 billion ($8.5 billion for HIV and $1billion for TB) for HIV and TB research and vaccine development during 11-year period from 2009 to 2019,” according to the statistical data compiled by Treatment Action Group (TAG-USA). “According t...

Failure: Why Did Nazi Germany Lose the War Despite Their Wonder Weapons? - Vimarsana News

Failure: Why Did Nazi Germany Lose the War Despite Their Wonder Weapons?

No amount of high-tech special systems could save Berlin from a two-front war. Key point: The Allies simply outproduced Germany and had more resources to use to win. In fact, some of Hitler's vanity wonder projects may have come at the cost of trying to win or come to a truce. During Germany’s early string of victories between 1939 and 1941, Hitler informed the members of the nation’s aerospace industry that he had decided to impose new restrictions on aircraft research and development. However, by 1942 the Führer and his Air Force High Command (Oberkommando der Luftwaffe) had recognize...